DD Support Board and Research Team

[namtae]

Its about as logical as it gets.

Is there any at all links to such a unrealistic statement?

In cancer, this is extremely common in Phase 1 safety/toxicity studies. Why? Because if the treatment is indeed toxic, the downside is limited. In the case of Oncolix, the patients were heavily treated previously and are now unresponsive. Their life expectancy is months.

Therefore, the risk is minimal.

Question:: Why on earth would a study treat "healthy patients", as was suggested previously, to determine just how toxic the treatment is?

Its really boiler plate